Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers-Reference-Cited by-同舟云学术

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers

Published:2018-11-29 Issue:5 Volume:125 Page:698-703
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Laitman Yael¹,Michaelson‐Cohen Rachel²,Levi Einat²,Chen‐Shtoyerman Rakefet³,Reish Orit⁴,Josefsberg Ben‐Yehoshua Sagi³,Bernstein‐Molho Rinat⁵⁶,Keinan‐Boker Lital⁷⁸,Rosengarten Ora⁹,Silverman Barbara G.⁷,Perri Tamar¹⁰⁶,Korach Jacob¹⁰⁶,Mor Pnina²,Ephrat Ben‐Baruch Noa¹¹,Levy Lahad Ephrat²,Friedman Eitan¹⁶^ORCID,

Affiliation:

1. Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical Center Tel‐Hashomer Israel

2. Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School of Medicine Jerusalem Israel

3. Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine Jerusalem Israel

4. Genetics Institute, Assaf Harofe Medical Center Zerifin Israel

5. Breast Cancer Unit, Oncology Institute, Chaim Sheba Medical Center Tel‐Hashomer Israel

6. Sackler School of Medicine Tel‐Aviv University Tel‐Aviv Israel

7. Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center Tel‐Hashomer Israel

8. School of Public Health University of Haifa Haifa Israel

9. Gyneco‐Oncology Unit, Institute of Oncology, Shaare Zedek Medical Center, Hebrew University School of Medicine Jerusalem Israel

10. Department of Gyneco‐Oncology Sheba Medical Center Tel‐Hashomer Israel

11. Oncology Department Kaplan Medical Center, Rehovot, Hebrew University School of Medicine Jerusalem Israel

Funder

Israel Cancer Association

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31842

Reference26 articles.

1. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

2. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

3. Cancer Incidence in BRCA1 Mutation Carriers

4. Cancer Risks in BRCA2 Mutation Carriers

5. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer;Journal of Cancer Research and Clinical Oncology;2024-09-11

2. Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer;Life;2024-09-03

3. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

4. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer;Cancer Treatment Reviews;2024-05

5. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis;BMC Genomic Data;2024-01-31